CLB
Income statement / Annual
Last year (2024), Core Laboratories N.V.'s total revenue was $523.85 M,
an increase of 2.76% from the previous year.
In 2024, Core Laboratories N.V.'s net income was $31.40 M.
See Core Laboratories N.V.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$523.85 M |
$509.79 M |
$489.74 M |
$470.25 M |
$487.27 M |
$668.21 M |
$700.85 M |
$659.81 M |
$594.74 M |
$797.52 M |
| Cost of Revenue |
$435.48 M
|
$415.74 M
|
$410.82 M
|
$386.41 M
|
$395.63 M
|
$518.18 M
|
$520.05 M
|
$499.18 M
|
$469.52 M
|
$560.11 M
|
| Gross Profit |
$88.37 M
|
$94.05 M
|
$78.92 M
|
$83.84 M
|
$91.63 M
|
$150.03 M
|
$180.80 M
|
$160.63 M
|
$125.23 M
|
$237.41 M
|
| Gross Profit Ratio |
0.17
|
0.18
|
0.16
|
0.18
|
0.19
|
0.22
|
0.26
|
0.24
|
0.21
|
0.3
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$38.59 M
|
$40.26 M
|
$38.12 M
|
$44.17 M
|
$34.03 M
|
$48.02 M
|
$62.91 M
|
$47.74 M
|
$39.39 M
|
$49.73 M
|
| Selling & Marketing Expenses |
$0.00
|
-$1.37 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$38.59 M
|
$38.89 M
|
$38.12 M
|
$44.17 M
|
$34.03 M
|
$48.02 M
|
$62.91 M
|
$47.74 M
|
$39.39 M
|
$49.73 M
|
| Other Expenses |
-$8.78 M
|
$515,000.00
|
-$722,000.00
|
$5.60 M
|
-$1.83 M
|
-$5.32 M
|
$737,000.00
|
-$452,000.00
|
$344,000.00
|
-$3.67 M
|
| Operating Expenses |
$29.82 M
|
$39.41 M
|
$37.40 M
|
$44.17 M
|
$34.03 M
|
$48.02 M
|
$62.91 M
|
$47.74 M
|
$39.39 M
|
$49.73 M
|
| Cost And Expenses |
$465.29 M
|
$455.15 M
|
$448.21 M
|
$430.59 M
|
$429.67 M
|
$566.21 M
|
$582.96 M
|
$546.92 M
|
$508.91 M
|
$609.84 M
|
| Interest Income |
$0.00
|
$0.00
|
$11.57 M
|
$9.15 M
|
$14.37 M
|
$14.69 M
|
$0.00
|
$0.00
|
$0.00
|
$56,000.00
|
| Interest Expense |
$12.37 M
|
$13.43 M
|
$11.57 M
|
$9.15 M
|
$14.37 M
|
$14.69 M
|
$13.33 M
|
$10.73 M
|
$11.57 M
|
$12.38 M
|
| Depreciation & Amortization |
$14.95 M
|
$15.78 M
|
$17.16 M
|
$18.52 M
|
$20.87 M
|
$22.61 M
|
$23.09 M
|
$24.52 M
|
$26.87 M
|
$27.46 M
|
| EBITDA |
$73.51 M |
$70.42 M |
$58.69 M |
$63.78 M |
-$56.50 M |
$119.29 M |
$141.71 M |
$134.49 M |
$114.32 M |
$188.53 M |
| EBITDA Ratio |
0.14
|
0.14
|
0.12
|
0.14
|
0.16
|
0.18
|
0.2
|
0.21
|
0.14
|
0.23
|
| Operating Income Ratio |
0.11
|
0.11
|
0.08
|
0.1
|
0.11
|
0.14
|
0.17
|
0.17
|
0.14
|
0.2
|
| Total Other Income/Expenses Net |
-$12.37 M
|
-$13.43 M
|
-$11.57 M
|
-$9.15 M
|
-$14.37 M
|
-$14.69 M
|
-$13.33 M
|
-$8.26 M
|
-$11.57 M
|
-$12.38 M
|
| Income Before Tax |
$46.19 M
|
$41.21 M
|
$29.95 M
|
$36.11 M
|
-$91.18 M
|
$81.99 M
|
$105.29 M
|
$101.71 M
|
$74.61 M
|
$148.69 M
|
| Income Before Tax Ratio |
0.09
|
0.08
|
0.06
|
0.08
|
-0.19
|
0.12
|
0.15
|
0.15
|
0.13
|
0.19
|
| Income Tax Expense |
$14.03 M
|
$4.19 M
|
$10.30 M
|
$15.89 M
|
$5.90 M
|
-$12.29 M
|
$25.45 M
|
$18.61 M
|
$10.75 M
|
$33.76 M
|
| Net Income |
$31.40 M
|
$36.68 M
|
$19.45 M
|
$19.73 M
|
-$97.07 M
|
$101.98 M
|
$79.53 M
|
$83.13 M
|
$63.90 M
|
$114.85 M
|
| Net Income Ratio |
0.06
|
0.07
|
0.04
|
0.04
|
-0.2
|
0.15
|
0.11
|
0.13
|
0.11
|
0.14
|
| EPS |
0.66 |
0.79 |
0.42 |
0.51 |
-2.18 |
2.11 |
1.8 |
1.88 |
1.45 |
2.71 |
| EPS Diluted |
0.66 |
0.77 |
0.42 |
0.5 |
-2.16 |
2.1 |
1.79 |
1.88 |
1.45 |
2.68 |
| Weighted Average Shares Out |
$47.69 M
|
$46.68 M
|
$46.33 M
|
$46.01 M
|
$44.48 M
|
$44.36 M
|
$44.21 M
|
$44.15 M
|
$43.48 M
|
$42.38 M
|
| Weighted Average Shares Out Diluted |
$47.69 M
|
$47.52 M
|
$46.81 M
|
$46.69 M
|
$44.97 M
|
$44.65 M
|
$44.47 M
|
$44.26 M
|
$44.15 M
|
$42.91 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
